{"id":552,"date":"2021-12-05T14:43:44","date_gmt":"2021-12-05T19:43:44","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/concept-map-metabolic-regulation\/"},"modified":"2023-03-03T11:39:12","modified_gmt":"2023-03-03T16:39:12","slug":"concept-map-metabolic-regulation","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/concept-map-metabolic-regulation\/","title":{"raw":"Concept Map: Glucose Regulation","rendered":"Concept Map: Glucose Regulation"},"content":{"raw":"\"Glucose\r\n

Image Description<\/h1>\r\nThis flowchart describes the Concept of Glucose Regulation.\u00a0 In the centre of the chart, Glucose Regulation is defined.\r\n\r\nThe definition of the Concept of Glucose Regulation is: the process of maintaining optimal blood glucose levels.\r\n\r\nNext, there are 3 arrows pointing from the definition to the Scope of Glucose Regulation.\u00a0 The scope is divided into 3 categories: Hypoglycemia (BG < 3.9 mmol\/L), Euglycemia (BG 4.0 \u2013 8.0 mmol\/L), and Hyperglycemia (BG > 8.0 mmol\/L).\r\n\r\nNext, one arrow points from the definition to the Variation of Glucose Regulation. An imbalance of glucose regulation results in either too much (hyperglycemia<\/strong>) or insufficient glucose (hypoglycemia<\/strong>). Both hyperglycemia and hypoglycemia are further described.\r\n\r\nHyperglycemia can be caused by: insufficient insulin production\/ secretion; deficient hormone signaling; and\/or excessive counterregulatory hormone secretion.\r\n\r\nHypoglycemia can be caused by: insufficient nutritional intake; adverse reaction to medications; excessive exercise, and\/or consequence of disease states.\r\n\r\nNext, an arrow points down towards Assessment for Glucose Regulation.\u00a0 Here, a summary of hypoglycemia and hyperglycemia symptoms are listed.\r\n\r\nHypoglycemia: Reduced cognition, Tremors, Diaphoresis, Weakness, Hunger, Headache, Irritability, Seizure.\r\n\r\nHyperglycemia: Polyuria, Polydipsia, Dehydration, Fatigue, Fruity odor to breath, Kussmaul breathing, Weight loss, Poor wound healing","rendered":"

\"Glucose<\/p>\n

Image Description<\/h1>\n

This flowchart describes the Concept of Glucose Regulation.\u00a0 In the centre of the chart, Glucose Regulation is defined.<\/p>\n

The definition of the Concept of Glucose Regulation is: the process of maintaining optimal blood glucose levels.<\/p>\n

Next, there are 3 arrows pointing from the definition to the Scope of Glucose Regulation.\u00a0 The scope is divided into 3 categories: Hypoglycemia (BG < 3.9 mmol\/L), Euglycemia (BG 4.0 \u2013 8.0 mmol\/L), and Hyperglycemia (BG > 8.0 mmol\/L).<\/p>\n

Next, one arrow points from the definition to the Variation of Glucose Regulation. An imbalance of glucose regulation results in either too much (hyperglycemia<\/strong>) or insufficient glucose (hypoglycemia<\/strong>). Both hyperglycemia and hypoglycemia are further described.<\/p>\n

Hyperglycemia can be caused by: insufficient insulin production\/ secretion; deficient hormone signaling; and\/or excessive counterregulatory hormone secretion.<\/p>\n

Hypoglycemia can be caused by: insufficient nutritional intake; adverse reaction to medications; excessive exercise, and\/or consequence of disease states.<\/p>\n

Next, an arrow points down towards Assessment for Glucose Regulation.\u00a0 Here, a summary of hypoglycemia and hyperglycemia symptoms are listed.<\/p>\n

Hypoglycemia: Reduced cognition, Tremors, Diaphoresis, Weakness, Hunger, Headache, Irritability, Seizure.<\/p>\n

Hyperglycemia: Polyuria, Polydipsia, Dehydration, Fatigue, Fruity odor to breath, Kussmaul breathing, Weight loss, Poor wound healing<\/p>\n","protected":false},"author":90,"menu_order":8,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":["amanda-egert","kimberly-lee","manu-gill"],"pb_section_license":""},"chapter-type":[],"contributor":[70,71,72],"license":[],"class_list":["post-552","chapter","type-chapter","status-publish","hentry","contributor-amanda-egert","contributor-kimberly-lee","contributor-manu-gill"],"part":527,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/90"}],"version-history":[{"count":3,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/552\/revisions"}],"predecessor-version":[{"id":1570,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/552\/revisions\/1570"}],"part":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/527"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/552\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=552"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=552"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=552"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}